Skip to main content

Market Overview

20 Healthcare Stocks Moving In Monday's Pre-Market Session

Share:

Gainers

Sorrento Therapeutics, Inc. (NASDAQ:SRNE) stock rose 45.27% to $9.82 during Monday's pre-market session. The most recent rating by H.C. Wainwright, on Mar 30, is at Buy, with a price target of $24.

Aurora Cannabis, Inc. (NYSE:ACB) shares rose 30.28% to $14.20. The most recent rating by Piper Sandler, on May 15, is at Neutral, with a price target of $10.

Diffusion Pharmaceuticals, Inc. (NASDAQ:DFFN) stock rose 23.70% to $1.67.

Fulgent Genetics, Inc. (NASDAQ:FLGT) stock rose 23.25% to $20.20. The most recent rating by Credit Suisse, on May 5, is at Neutral, with a price target of $11.

Kitov Pharma, Inc. (NASDAQ:KTOV) stock moved upwards by 22.10% to $0.60.

Trevena, Inc. (NASDAQ:TRVN) shares rose 12.38% to $1.18.

Vir Biotechnology, Inc. (NASDAQ:VIR) shares increased by 11.30% to $33.78. The most recent rating by Baird, on Mar 27, is at Underperform, with a price target of $20.

Auris Medical Holding, Inc. (NASDAQ:EARS) shares rose 11.21% to $1.19.

HEXO, Inc. (NYSE:HEXO) shares increased by 10.99% to $0.59. The most recent rating by Roth Capital, on Mar 31, is at Neutral, with a price target of $1.

Mesoblast, Inc. (NASDAQ:MESO) stock rose 9.88% to $13.01.

 

Losers

ChemoCentryx, Inc. (NASDAQ:CCXI) shares decreased by 10% to $48.42 during Monday's pre-market session. The most recent rating by JP Morgan, on May 14, is at Overweight, with a price target of $64.

PDL BioPharma, Inc. (NASDAQ:PDLI) stock fell 8.81% to $2.90.

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) shares decreased by 7.64% to $0.25.

Tetraphase Pharmaceutical, Inc. (NASDAQ:TTPH) stock declined 6.85% to $2.04. According to the most recent rating by Gabelli & Co., on Mar 17, the current rating is at Sell.

Aptevo Therapeutics, Inc. (NASDAQ:APVO) shares fell 6.40% to $5.12.

PLx Pharma, Inc. (NASDAQ:PLXP) shares declined 6.25% to $2.55.

Seneca Biopharma, Inc. (NASDAQ:SNCA) shares decreased by 5.98% to $0.86.

Atossa Therapeutics, Inc. (NASDAQ:ATOS) stock fell 5.88% to $1.60.

Menlo Therapeutics, Inc. (NASDAQ:MNLO) shares fell 5.33% to $1.60. The most recent rating by HC Wainwright & Co., on May 12, is at Buy, with a price target of $2.

VistaGen Therapeutics, Inc. (NASDAQ:VTGN) shares decreased by 5% to $0.38.

 

Related Articles (SRNE + ACB)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversPre-Market Outlook Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com